02/28/2026
Lipoprotein(a) is genetically determined and independently increases cardiovascular risk.
I’m currently at the Clinical Applications of Longevity Medicine Conference, and one takeaway stood out.
2025 prospective data showed something important:
When elevated Lp(a) was combined with a high waist-to-hip ratio, cardiovascular risk increased nearly two-fold compared to normal fat distribution.
Visceral fat is metabolically active. Pro-inflammatory. Atherogenic.
You can’t change your genes.
But you can reduce central adiposity.
And that meaningfully alters trajectory.
This is why I measure:
• Lp(a)
• ApoB
• Waist-to-hip ratio
• Visceral fat (DEXA when possible)
Longevity isn’t about chasing one biomarker.
It’s about understanding how they interact.